Evidence map›Paper›PMID 32906649›Full record

ArticleCancers2020

Federica Isidori, Isotta Bozzarelli, Simona Ferrari, Lea Godino, Giovanni Innella, Daniela Turchetti, Elena Bonora

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Federica IsidoriGenetic Laboratory, Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Isotta BozzarelliGenetic Laboratory, Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Simona FerrariUnit of Medical Genetics, Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy.
Lea GodinoUnit of Medical Genetics, Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi, 40138 Bologna, Italy.ORCID 0000-0002-3763-9372
Giovanni InnellaGenetic Laboratory, Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.ORCID 0000-0002-6909-2412
Daniela TurchettiGenetic Laboratory, Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Elena BonoraGenetic Laboratory, Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITUniversity of Bologna · IT

Funding

ER-Programma Giovani Ricercatori PRUa1GR-2012-001
6 · The paper itself

Abstract

Breast cancer (BC) is the second leading cause of death in women. BC patients with family history or clinical features suggestive of inherited predisposition are candidate to genetic testing to determine whether a hereditary cancer syndrome is present. We aimed to identify new predisposing variants in familial BC patients using next-generation sequencing approaches. We performed whole exome sequencing (WES) in first-degree cousin pairs affected by hereditary BC negative at the

Indexed as

breast cancerRASAL1ROS1whole exome sequencing

Identifiers

PMID32906649
PMCPMC7563829
OpenAlexW3083643509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.